Back to results
US 2006/0224205 A1Published application
System and method for remote pacing threshold assessment
AssigneeMedtronic, Inc.
InventorsCharles Yerich, Karen Kleckner
Life of this patent
Estimating the term…
Abstract
A cardiac rhythm management system includes an implantable medical device capable of delivering cardiac therapy and sensing an EGM. The implantable medical device undergoes threshold testing and transmits testing data to a computer via a remote monitor.
Claims20
A cardiac rhythm management system comprising:
- an implantable medical device capable of delivering cardiac therapy and sensing EGM signals and producing EGM waveform data, the IMD being programmed to perform threshold testing related to the cardiac therapy, during which test data including EGM waveform data is obtained;
- a remote monitor for communicating with the implantable medical device by telemetry for receiving the test data;
- and
- a computer operatively connected to the remote monitor, wherein the computer receives the test data from the remote monitor;
- wherein the computer is operatively connected to the remote monitor through a phone or Internet connection.
2 more elements
(canceled)
A system for remote cardiac pacing threshold assessment, the system comprising:
- means for providing cardiac pacing to a heart;
- means for sensing EGM signals from the heart and producing EGM waveform data;
- means for remotely interrogating the means for providing cardiac pacing and the means for sensing an EGM;
- and
- means for responding to a signal to initiate remote cardiac pacing threshold assessment testing, wherein, during testing, the remote monitor receives testing data including the EGM waveform data produced by the means for sensing EGM signals.
2 more elements
A method of remote cardiac pacing threshold assessment, the method comprising:
- initiating cardiac pacing threshold assessment testing of an implantable medical device;
- sensing an EGM of a heart during cardiac pacing threshold assessment testing;
- and
- transmitting a signal from the implantable medical device, wherein the signal includes the EGM sensed during a testing time period and annotation.
1 more element
Dependencies are inferred from the claim text.